← Eichor
Study identifier: NCT01929356 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia

Condition: Primary Ciliary Dyskinesia  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseNA
Planned participants29
Who can joinAll sexes, 6 Years to 50 Years
Healthy volunteersNo

About this study

Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.

This description comes directly from the study's public registry record.

Talk to the study team

Mieke Boon, MD  ·  +3216342589  ·  mieke.boon@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Gasthuisberg LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01929356